Core Insights - MetLife reported $19.74 billion in revenue for Q4 2024, a year-over-year increase of 5.5% [1] - The EPS for the same period was $2.08, compared to $1.93 a year ago, but fell short of the consensus estimate of $2.13, resulting in an EPS surprise of -2.35% [1] Revenue Performance - The reported revenue exceeded the Zacks Consensus Estimate of $19.23 billion, representing a surprise of +2.65% [1] - Revenue from premiums was $12.62 billion, surpassing the average estimate of $12.08 billion, reflecting a +7.1% year-over-year change [4] - Other revenues amounted to $641 million, slightly above the estimated $635.59 million, but showed a -2.9% change compared to the previous year [4] Adjusted Revenue Metrics - Adjusted revenue from Corporate & other net investment income was $126 million, exceeding the estimate of $91.17 million, marking a +28.6% change year-over-year [4] - Adjusted revenue from Retirement & Income Solutions premiums reached $3.46 billion, significantly higher than the estimate of $2.20 billion, with a year-over-year increase of +26.5% [4] - Adjusted revenue from Latin America net investment income was $431 million, slightly below the estimate of $436.74 million, reflecting a -10.6% change year-over-year [4] Stock Performance - MetLife shares returned +3% over the past month, outperforming the Zacks S&P 500 composite's +1.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Group 1 - MetLife reported quarterly earnings of $2.08 per share, missing the Zacks Consensus Estimate of $2.13 per share, but showing an increase from $1.93 per share a year ago, resulting in an earnings surprise of -2.35% [1] - The company posted revenues of $19.74 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 2.65% and increasing from $18.72 billion year-over-year [2] - Over the last four quarters, MetLife has surpassed consensus EPS estimates only once, while it has topped consensus revenue estimates two times [2] Group 2 - The immediate price movement of MetLife's stock will depend on management's commentary during the earnings call and future earnings expectations [3] - MetLife shares have gained approximately 3.4% since the beginning of the year, outperforming the S&P 500's gain of 2.7% [3] - The current consensus EPS estimate for the upcoming quarter is $2.09 on revenues of $18.22 billion, and for the current fiscal year, it is $9.63 on revenues of $75.37 billion [7] Group 3 - The outlook for the Insurance - Multi line industry, to which MetLife belongs, is currently in the bottom 45% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact MetLife's stock performance [5] - The current estimate revisions trend for MetLife is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6]

Revenue and Income - Total revenues for the year ended December 31, 2024, were $70,986 million, an increase from $66,905 million in 2023, representing a growth of approximately 3.2%[5] - Net income attributable to MetLife, Inc. for the year ended December 31, 2024, was $4,426 million, compared to $4,444 million in 2023, showing a slight decrease of about 0.4%[5] - Premiums for the fourth quarter of 2024 were $12,617 million, up from $10,647 million in the same quarter of 2023, reflecting a growth of approximately 18.5%[5] - Adjusted earnings available to common shareholders for the year ended December 31, 2024, were $52,520 million, compared to $51,961 million in 2023, reflecting an increase of about 1.1%[5] - Net income available to common shareholders for Q4 2023 was $574 million, increasing to $1,239 million by Q4 2024, representing a growth of 115%[6] - Adjusted earnings available to common shareholders for the year ended December 31, 2024, were $1,621 million, up from $1,282 million in 2023, representing a growth of 26.5%[26] Expenses and Ratios - Total expenses for the year ended December 31, 2024, were $65,364 million, a slight increase from $64,743 million in 2023, indicating a growth of approximately 1%[5] - The expense ratio for the year ended December 31, 2024, was 19.0%, compared to 18.7% for the year ended December 31, 2023[14] - Direct expense ratio for the year ended December 31, 2024, was 10.7%, a decrease from 11.2% in the previous year[14] - The adjusted expense ratio for the year ended December 31, 2024, was 18.8%, slightly up from 18.6% in the previous year[14] - Total adjusted expenses for the three months ended December 31, 2024, were $2,273 million, compared to $2,289 million in the previous year, showing a decrease of 0.7%[26] Investment Income - Net investment income for the year ended December 31, 2024, increased to $21,273 million from $19,908 million in 2023, marking a growth of about 6.8%[5] - Adjusted net investment income for the year ended December 31, 2024, is expected to reach $20,672 million, an increase from $19,749 million in 2023, indicating a growth of about 4.7%[12] - Variable investment income included in net investment income for the year ended December 31, 2024, is projected to be $1,013 million, up from $419 million in 2023, showing a significant increase of about 141%[12] - The company reported net investment losses of $(174) million in Q4 2023, which improved to $(311) million in Q4 2024[6] Assets and Liabilities - The company’s total assets under management in Asia increased, with specific measures detailed in the financial supplement[3] - Total assets decreased to $677,457 million by December 31, 2024, down from $704,976 million in September 2024[16] - The total liabilities as of December 31, 2024, were $649,754 million, a decrease from $673,812 million in September 2024[16] - The equity of MetLife, Inc. decreased to $27,703 million by December 31, 2024, from $31,164 million in September 2024[16] Future Growth and Strategy - Future policy benefits and policyholder account balances were highlighted as key areas for growth and focus in the upcoming fiscal year[3] - The company anticipates a stable growth trajectory in adjusted revenues and net investment income, driven by strategic market expansions and product innovations[12] Notable Items and Adjustments - Total notable items impacting adjusted earnings available to common shareholders were $(76) million in Q4 2023, with a slight recovery to $10 million in Q4 2024[6] - The company reported a net credit loss provision release and impairments of $(67) million for the three months ended December 31, 2023[43] - The company’s total notable items for the year ended December 31, 2023, were $(62) million, compared to $26 million in 2022, indicating a negative shift in notable items[55] Regional Performance - Adjusted earnings available to common shareholders for Asia for Q4 2023 were $291 million, with a forecast of $443 million for Q4 2024[67] - Latin America reported adjusted earnings of $182 million in Q4 2023, with a slight decrease to $201 million projected for Q4 2024[67] - EMEA adjusted earnings for Q4 2023 were $45 million, with a forecasted decrease to $59 million in Q4 2024[67] Stockholder Equity - MetLife's common stockholders' equity as of December 31, 2023, was $26,197 million, with a book value per common share of $35.85[62] - The adjusted return on MetLife's common stockholders' equity for the year ended December 31, 2023, was 16.9%[62] - Adjusted common stockholders' equity, excluding total notable items, was $39,343 million as of December 31, 2023[62]

MetLife, Inc. (MET) is set to report fourth-quarter 2024 results on Feb. 5, 2025, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings per share (EPS) is currently pegged at $2.13 on revenues of $19.2 billion.See the Zacks Earnings Calendar to stay ahead of market-making news.The fourth-quarter earnings estimate has been revised downward over the past 60 days. However, the bottom-line projection indicates a year-over-year increase of 10.4%. The Zacks Consensus Estim ...

Wall Street analysts expect MetLife (MET) to post quarterly earnings of $2.13 per share in its upcoming report, which indicates a year-over-year increase of 10.4%. Revenues are expected to be $19.23 billion, up 2.7% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 3.1% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earnings anno ...

Company Overview - MetLife (MET) is expected to report a year-over-year increase in earnings, with a projected EPS of $2.13, reflecting a +10.4% change, and revenues of $19.23 billion, up 2.7% from the previous year [3][12] - The upcoming earnings report is scheduled for February 5, 2024, and the stock may react positively if results exceed expectations, while a miss could lead to a decline [2][3] Earnings Estimates and Revisions - The consensus EPS estimate has been revised 3.09% lower in the last 30 days, indicating a bearish sentiment among analysts regarding MetLife's earnings prospects [4][10] - The Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.56%, which complicates the prediction of an earnings beat [10][11] Earnings Surprise History - In the last reported quarter, MetLife was expected to post earnings of $2.16 per share but only achieved $1.93, resulting in a surprise of -10.65% [12] - Over the past four quarters, MetLife has only beaten consensus EPS estimates once [13] Comparison with Industry Peers - Prudential (PRU), another player in the insurance industry, is expected to report an EPS of $3.28 for the same quarter, indicating a +27.1% year-over-year change, with revenues projected at $14.15 billion, up 8.7% [17] - Prudential's consensus EPS estimate has also been revised 0.6% lower, leading to an Earnings ESP of -1.07%, making it similarly challenging to predict an earnings beat [18]

Company Performance - MetLife's stock gained 28% over the last year, outperforming the S&P 500 index, which returned 23% [1] - Prudential Financial, a peer company, saw a 19% stock increase over the same period [1] - Q3 adjusted operating revenues declined 3.4% year-over-year to $17.6 billion [1] - Premiums, fees, and other revenues decreased by approximately 5%, while investment-related income rose 8% [1] - Adjusted earnings were $1.93 per share, impacted by a 7.3% year-over-year increase in expenses due to higher interest credited to policyholder account balances [1] - The group benefits business underperformed, particularly in non-medical health underwriting and actuarial assumption review [1] Market Trends and Outlook - The U.S. Federal Reserve's slower path toward monetary easing could benefit MetLife, as life insurers are more sensitive to interest rates due to their long-term bond-heavy investment strategies [2] - Potential regulatory and tax changes under the Trump administration may improve profitability for insurers like MetLife [2] - MetLife has been growing its dividend yield and maintains a strong share buyback program, which could drive long-term gains [2] - At $82 per share, MetLife's stock is trading 5% below Trefis' estimated valuation of $86 per share [2] Comparative Analysis - The Trefis High Quality Portfolio, consisting of 30 stocks, has provided better returns with less risk compared to the S&P 500 index over the last four years [2]

Company Overview - MetLife Investment Management (MIM) has entered into a definitive agreement to acquire PineBridge Investments, which has approximately $100 billion in assets under management. The deal includes $800 million in cash at closing, with additional contingent payments based on financial metrics and earnouts [6] - The acquisition aligns with MetLife's New Frontier strategy aimed at accelerating asset management growth and enhancing MIM's competitiveness through PineBridge's global footprint and investment expertise [1][6] Financial Impact - Upon completion, MIM's total assets under management (AUM) are expected to exceed $700 billion, significantly enhancing its scale and broadening its global offerings. MIM's AUM was $609.3 billion as of September 30, 2024 [2] - The transaction is anticipated to be neutral to earnings per share in the first year and accretive thereafter, supported by potential expense synergies and a capital-light structure [1][6] Market Context - The asset management industry is facing intense competition due to evolving client needs and increased regulations, prompting companies to strengthen their positions through expansion [7] - The acquisition is expected to enhance MIM's product offerings and attract a larger customer base, particularly as over half of the client assets acquired are owned by investors outside the United States, with one-third owned by investors in Asia [1][7] Performance Metrics - MetLife's shares have gained 14.4% in the past six months, outperforming the industry growth of 3.1% [8] - MetLife currently holds a Zacks Rank 4 (Sell), indicating a need for cautious evaluation despite recent performance [9]

Core Insights - MetLife has launched a new five-year strategy called "New Frontier" aimed at enhancing long-term growth and profitability [1][2] - The plan targets double-digit adjusted earnings per share (EPS) growth, a 15% to 17% adjusted return on equity, a one-percentage-point reduction in direct expense ratio, and $25 billion in free cash flow [1] - Following the announcement, MetLife's shares increased by 5% [1] Group 1: Strategy Overview - The "New Frontier" strategy builds on the previous "Next Horizon" plan, which focused on simplifying and differentiating the company [2] - CEO Michel Khalaf emphasized that MetLife operates in attractive markets with strong competitive advantages, allowing for growth with lower risk [2] Group 2: Key Focus Areas - The "New Frontier" strategy will concentrate on four main areas: enhancing leadership in group benefits, leveraging a unique retirement platform, accelerating asset management growth, and expanding in high-growth international markets [2]

Core Insights - MetLife, Inc. and General Atlantic are launching Chariot Reinsurance, Ltd., a Bermuda-based life and annuity reinsurer, set to commence operations in 2025, backed by over $1 billion in equity investment [1][2] - The formation of Chariot Re will allow MetLife to transfer approximately $10 billion in liabilities, optimizing its balance sheet and enhancing financial flexibility [2] - MetLife will manage Chariot Re's investment portfolio exclusively, creating a new revenue stream and leveraging its expertise in complex asset management [3] Financial Implications - The transfer of liabilities to Chariot Re will reduce MetLife's risk exposure and free up capital for reinvestment in higher return areas [2] - MetLife's shares have increased by 9.4% over the past three months, outperforming the industry growth of 5.3% [5] Market Context - The launch of Chariot Re is timely, as there is a rising global demand for life insurance, reinsurance, and retirement solutions, which MetLife can capitalize on through innovative reinsurance offerings [4] - The collaboration with General Atlantic is expected to support sustainable growth for Chariot Re in the long term [4]